Sixteen hours of fasting differentially affects hepatic and muscle insulin sensitivity in mice

被引:76
作者
Heijboer, AC [1 ]
Donga, E
Voshol, PJ
Dang, ZC
Havekes, LM
Romijn, JA
Corssmit, EPM
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands
[2] Netherlands Org Appl Sci Res TNO Prevnet & Hlth, Gaubius Lab, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
关键词
glucose metabolism; steatosis; insulin action; transcription factors; isotopes;
D O I
10.1194/jlr.M400440-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fasting readily induces hepatic steatosis. Hepatic steatosis is associated with hepatic insulin resistance. The purpose of the present study was to document the effects of 16 h of fasting in wild-type mice on insulin sensitivity in liver and skeletal muscle in relation to 1) tissue accumulation of triglycerides (TGs) and 2) changes in mRNA expression of metabolically relevant genes. Sixteen hours of fasting did not show an effect on hepatic insulin sensitivity in terms of glucose production in the presence of increased hepatic TG content. In muscle, however, fasting resulted in increased insulin sensitivity, with increased muscle glucose uptake without changes in muscle TG content. In liver, fasting resulted in increased mRNA expression of genes promoting gluconeogenesis and TG synthesis but in decreased mRNA expression of genes involved in glycogenolysis and fatty acid synthesis. In muscle, increased mRNA expression of genes promoting glucose uptake, as well as lipogenesis and beta-oxidation, was found. In conclusion, 16 h of fasting does not induce hepatic insulin resistance, although it causes liver steatosis, whereas muscle insulin sensitivity increases without changes in muscle TG content. Therefore, fasting induces differential changes in tissue-specific insulin sensitivity, and liver and muscle TG contents are unlikely to be involved in these changes.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 36 条
  • [11] CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice
    Goudriaan, JR
    Dahlmans, VEH
    Teusink, B
    Ouwens, DM
    Febbraio, M
    Maassen, JA
    Romijn, JA
    Havekes, LM
    Voshol, PJ
    [J]. JOURNAL OF LIPID RESEARCH, 2003, 44 (12) : 2270 - 2277
  • [12] Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity
    Guerre-Millo, M
    Gervois, P
    Raspé, E
    Madsen, L
    Poulain, P
    Derudas, B
    Herbert, JM
    Winegar, DA
    Willson, TM
    Fruchart, JC
    Berge, RK
    Staels, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) : 16638 - 16642
  • [13] Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance
    Hammarstedt, A
    Jansson, PA
    Wesslau, C
    Yang, X
    Smith, U
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (02) : 578 - 582
  • [14] Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting
    Hashimoto, T
    Cook, WS
    Qi, C
    Yeldandi, AV
    Reddy, JK
    Rao, MS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) : 28918 - 28928
  • [15] Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α
    Hertz, R
    Magenheim, J
    Berman, I
    Bar-Tana, J
    [J]. NATURE, 1998, 392 (6675) : 512 - 516
  • [16] Alterations in nutritional status regulate acetyl-CoA carboxylase expression in avian liver by a transcriptional mechanism
    Hillgartner, FB
    Charron, T
    Chesnut, KA
    [J]. BIOCHEMICAL JOURNAL, 1996, 319 : 263 - 268
  • [17] Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice
    Horton, JD
    Bashmakov, Y
    Shimomura, I
    Shimano, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) : 5987 - 5992
  • [18] Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting
    Kersten, S
    Seydoux, J
    Peters, JM
    Gonzalez, FJ
    Desvergne, B
    Wrahli, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) : 1489 - 1498
  • [19] Peroxisome proliferator-activated receptor-α agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis
    Kim, H
    Haluzik, M
    Asghar, Z
    Yau, D
    Joseph, JW
    Fernandez, AM
    Reitman, ML
    Yakar, S
    Stannard, B
    Heron-Milhavet, L
    Wheeler, MB
    LeRoith, D
    [J]. DIABETES, 2003, 52 (07) : 1770 - 1778
  • [20] DEVELOPMENT OF MUSCLE INSULIN RESISTANCE AFTER LIVER INSULIN RESISTANCE IN HIGH-FAT FED RATS
    KRAEGEN, EW
    CLARK, PW
    JENKINS, AB
    DALEY, EA
    CHISHOLM, DJ
    STORLIEN, LH
    [J]. DIABETES, 1991, 40 (11) : 1397 - 1403